Published: The demand in the global muconic acid market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory framework is substantially hindering the inflow of the demand for muconic acid. Nevertheless, the market for muconic acid is rapidly evolving with a growing preference for point-of-care testing as well as personalized medicine and the advent of cost-effective lab tests and integrated analytical systems are expected to open new opportunities for the merchants of this market.
Source: Biospace
